Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Pulmonary Embolism
Pulsed Field Ablation
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Pulmonary Embolism
Pulsed Field Ablation
Breadcrumb
Home /
News Index
Latest News
Sudden cardiac death rates may be seven times higher among young people with diabetes
14 November 2017
E-cigarette vapor slows heart rate in mice
13 November 2017
Thirty-Day Results of ABSORB IV Demonstrate that Improvements in Bioresorbable Stent Technology and…
01 November 2017
Written by:
Bayer
Bayer receives EU approval for Xarelto® ▼ 10 mg once daily for the extended prevention of venous…
01 November 2017
Written by:
OrbusNeich
Late-Breaking REDUCE Trial Data Demonstrate Non-inferiority of 3 vs 12 months Dual Antiplatelet Therapy in…
01 November 2017
Written by:
BIOTRONIK
TCT 2017: Magmaris Resorbable Magnesium Scaffold (RMS) Continues to Show No Instances of Scaffold Thrombosis
01 November 2017
Written by:
BIOTRONIK
TCT 2017: BIOTRONIK Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in…
31 October 2017
Written by:
REVA Medical
New Fantom Data Demonstrates Safety at 2 Years
31 October 2017
Written by:
OrbusNeich
OrbusNeich’s COMBOTM Dual Therapy Stent Demonstrates Non-inferiority vs the Market Leading XIENCETM…
30 October 2017
Treatment of heart attack patients depends on history of cancer
22 September 2017
Load More
External news
Written by:
Cardiac Vascular News
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
24 October 2024
Written by:
Cardiovascular Business
Americans know very little about vascular health, prompting surgeons to speak out
24 October 2024
Written by:
Cardiovascular Business
TAVR survival is down in recent years, leaving cardiologists stumped
24 October 2024
Written by:
Medscape
CVD 2050: No, GLP-1s Won't Save the Day
24 October 2024
Written by:
heart.org - Stroke news
Estudio ofrece ‘evidencia contundente’ para la mejora continua en la atención de derrames cerebrales
24 October 2024
Written by:
heart.org - Stroke news
Study offers ‘compelling evidence’ for continuous stroke care improvement
24 October 2024
Written by:
Cardiac Vascular News
Medtronic receives CE Mark for Evolut™ FX+ TAVI system for treatment of symptomatic severe aortic stenosis
24 October 2024
Written by:
Cardiac Vascular News
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
24 October 2024
Written by:
Cardiac Vascular News
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
24 October 2024
Written by:
Cardiac Vascular News
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
24 October 2024
Load More